Discovery of Biomarkers of Resistance to Immune Checkpoint Blockade in NSCLC Using High-Plex Digital Spatial ProfilingMyrto Moutafi, David L. Rimm, Sandra Martínez-Morilla et al.|Journal of Thoracic Oncology|2022Cited by 40
Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancerSaba Shafi, David L. Rimm, Thazin Nwe Aung et al.|Laboratory Investigation|2022Cited by 17
Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell CarcinomaNiki Gavrielatou, David L. Rimm, Ioannis Vathiotis et al.|Cancer Research Communications|2023Cited by 16
Development of an immunohistochemical assay for Siglec-15Saba Shafi, David L. Rimm, Thazin Nwe Aung et al.|Laboratory Investigation|2022Cited by 13
Programmed Death-Ligand 1 and Programmed Death-Ligand 2 mRNAs Measured Using Closed-System Quantitative Real-Time Polymerase Chain Reaction Are Associated With Outcome and High Negative Predictive Value in Immunotherapy-Treated NSCLCAileen I. Fernandez, David L. Rimm, Niki Gavrielatou et al.|Journal of Thoracic Oncology|2022Cited by 13